Filters
-
Thema
- Economie, Financiën, Bedrijf en Management
- Biografie, literatuur en literatuurstudies
- Samenleving en sociale wetenschappen
- Technologie, techniek, landbouw, industriële processen
- Geneeskunde en verpleging
- Fictie
- Naslagwerken, informatie en interdisciplinaire onderwerpen
- Wetgeving
- Kinderen, tieners en onderwijs
-
Productvorm
-
Taal
-
Prijs
Resultaten voor 'john carreyrou'
-
Bad Blood
'I couldn't put down this thriller . . . a book so compelling that I couldn't turn away' - Bill Gates'A story so incredible you'd think it was fiction' - James PattersonWinner of the Financial Times/McKinsey Business Book of the Year Award.The shocking true story of the breathtaking rise and collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, written by the prize-winning journalist who first broke the story and pursued it to the end.Seen as the female Steve Jobs, Theranos founder and CEO Elizabeth Holmes was a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by wealthy investors, Theranos sold shares that valued the company at more than $9 billion.There was just one problem: the technology didn't work . . .Despite threats of legal action, brave whistleblowers started to talk. They revealed a culture of intimidation and secrecy, technology that repeatedly failed, results sent to real patients that were incorrect but upon which life-changing medical decisions were being made, with devastating consequences.The riveting story behind The Dropout, in Bad Blood, John Carreyrou investigates the biggest corporate fraud since Enron, a tale of ambition and scandal set amid the bold promises of Silicon Valley.'A tale of corporate fraud and legal browbeating that reads like a crime thriller' - TIME, The 10 Best Nonfiction Books of the Year
€ 14,00 -
Bad Blood
'A story so incredible you'd think it was fiction' - James PattersonWinner of the Financial Times/McKinsey Business Book of the Year Award.The shocking true story of the breathtaking rise and collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes. Written by the prize-winning journalist who first broke the shocking story and pursued it to the end.'I couldn't put down this thriller . . . a book so compelling that I couldn't turn away' - Bill GatesSeen as the female Steve Jobs, Theranos founder and CEO Elizabeth Holmes was a brilliant Stanford dropout whose startup 'unicorn' promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by wealthy investors, Theranos sold shares that valued the company at more than $9 billion.There was just one problem: the technology didn't work . . .Despite threats of legal action, brave whistleblowers started to talk. They revealed a culture of intimidation and secrecy, technology that repeatedly failed, results sent to real patients that were incorrect but upon which life-changing medical decisions were being made, with devastating consequences.The riveting story behind The Dropout, in Bad Blood, John Carreyrou investigates the biggest corporate fraud since Enron, a tale of ambition and scandal set amid the bold promises of Silicon Valley.'A tale of corporate fraud and legal browbeating that reads like a crime thriller' - TIME, The 10 Best Nonfiction Books of the Year
€ 16,50 -
Bad Blood
Spannend wie ein Thriller: ein tiefer Einblick in die Schattenseiten des Silicon ValleyElizabeth Holmes, die Gründerin von Theranos, galt lange als der weibliche Steve Jobs. Das 19-jährige Start-up-Wunderkind versprach, mit ihrer Firma die Medizinindustrie zu revolutionieren. Ein einziger Tropfen Blut sollte reichen, um Diagnosen zu erstellen und Therapien zu steuern - eine Riesenhoffnung für Millionen Menschen und ein extrem lukratives Geschäft. Namhafte Investoren steckten Milliarden in das junge Unternehmen. Es gab nur ein einziges Problem: Die Technologie hat nie funktioniert. Pulitzer-Preisträger John Carreyrou kam dem gigantischen Betrug auf die Spur und erzählt in seinem preisgekrönten Buch die packende Geschichte seiner Enthüllung.
€ 15,00 -
Bad Blood
The Financial Times & McKinsey Business Book of the Year A New York Times Notable Book A Washington Post Notable Book One of the Best Books of the Year: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees. Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron-a tale of ambition and hubris set amid the bold promises of Silicon Valley.
€ 10,50 -
Bad Blood
The Financial Times & McKinsey Business Book of the Year A New York Times Notable Book A Washington Post Notable Book One of the Best Books of the Year: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees. Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron-a tale of ambition and hubris set amid the bold promises of Silicon Valley.
€ 12,50 -
Bloedfraude
E-bookDe biografie Bloedfraude, de Nederlandse vertaling van de New York Times-bestseller Bad Blood van Pulitzerprijswinnaar John Carreyrou, vertelt het verhaal van ‘de nieuwe Steve Jobs’ Elizabeth Holmes, wiens fraudezaak in 2021 voor de rechter kwam. Op haar negentiende richtte Elizabeth Holmes de meest veelbelovende start-up van Silicon Valley op: Theranos. Haar revolutionaire idee was een nieuwe, snelle manier van bloedtesten, die de medische wereld op zijn kop zou zetten. Al in het eerste jaar haalde Holmes het ongekende bedrag van 45 miljoen dollar op en haar portret prijkte op alle businesskranten en -bladen. Extraordinary, werd het genoemd. Maar haar bedrijf bleek gebaseerd op leugens en vervalste testresultaten, en Holmes voerde een schrikbewind om haar moedwillige fraude te verhullen. De meermaals bekroonde Wall Street Journal-journalist John Carreyrou ontmaskerde Holmes en zijn onthullingen brachten haar ten val. Zijn diepgravende journalistieke onderzoek is de basis voor dit adembenemende en shockerende boek over een evil woman en de waanzin van het snelle geld. Van Bloedfraude verschijnt in 2022 zowel een film als een miniserie. In de verfilming, Bad Blood, zal de hoofdrol door Jennifer Lawrence worden vertolkt. In de serie op Disney+, The Dropout, zullen acteurs als Amanda Seyfried, Stephen Fry, Sam Waterston en Elizabeth Marvel hun opwachting maken. ‘IJzingwekkend.’ – The New York Times ‘De liegende koningin van Silicon Valley.’ – Het Financieele Dagblad
€ 13,99